Establishment of a novel human fetal adrenal culture model that supports de novo and manipulated steroidogenesis
Open accessAbstract
Context: Disorders affecting adrenal steroidogenesis promote an imbalance in the normally tightly controlled secretion of mineralocorticoids, glucocorticoids, and androgens. This may lead to differences/disorders of sex development in the fetus, as seen in virilized girls with congenital adrenal hyperplasia (CAH). Despite the important endocrine function of human fetal adrenals, neither normal nor dysregulated adrenal steroidogenesis is understood in detail. Objective: Due to significant differences in adrenal steroidogenesis between human and model species (except higher primates), we aimed to establish a human fetal adrenal model that enables examination of both de novo and manipulated adrenal steroidogenesis. Design and Setting: Human adrenal tissue from 54 1st trimester fetuses were cultured ex vivo as intact tissue fragments for 7 or 14 days. Main Outcome Measures: Model validation included examination of postculture tissue morphology, viability, apoptosis, and quantification of steroid hormones secreted to the culture media measured by liquid chromatography-tandem mass spectrometry. Results: The culture approach maintained cell viability, preserved cell populations of all fetal adrenal zones, and recapitulated de novo adrenal steroidogenesis based on continued secretion of steroidogenic intermediates, glucocorticoids, and androgens. Adrenocorticotropic hormone and ketoconazole treatment of ex vivo cultured human fetal adrenal tissue resulted in the stimulation of steroidogenesis and inhibition of androgen secretion, respectively, demonstrating a treatment-specific response. Conclusions: Together, these data indicate that ex vivo culture of human fetal adrenal tissue constitutes a novel approach to investigate local effects of pharmaceutical exposures or emerging therapeutic options targeting imbalanced steroidogenesis in adrenal disorders, including CAH.
Verified 2026-10-10 · 1 reference not checked yet
AI snapshot
Written from the paper’s full text.
TL;DR
This paper establishes a hanging-drop ex vivo culture model of first-trimester human fetal adrenal tissue that preserves morphology, viability, and steroidogenic activity for up to 14 days. It further shows that steroidogenesis can be stimulated with ACTH and inhibited with ketoconazole, supporting use for studying normal and dysregulated human fetal adrenal function.
Key findings
- Human fetal adrenal tissue from 54 first-trimester fetuses (59 adrenals; GW 8–11) cultured as ~1 mm³ fragments maintained morphology, proliferation, and low apoptosis for 7–14 days; cPARP+ cells/mm² decreased 3.8-fold (p<0.05) at 14 days versus 7 days.
- Cultured tissue recapitulated de novo steroidogenesis: DHEAS was the most abundant measured metabolite (>20,000 nmol/L), cortisol was second highest (>1000 nmol/L), and testosterone was lowest (<5 nmol/L) but detectable in all samples, with no differences between 7- and 14-day cultures.
- ACTH (1 nM) after 14 days increased androstenedione 10.8-fold (p<0.01), testosterone 9.4-fold (p<0.05), DHEAS 2.5-fold (p<0.01), 17-hydroxyprogesterone 4.5-fold (p<0.01), 11-deoxycortisol 12.7-fold (p<0.01), cortisol 6.9-fold (p<0.01), cortisone 1.7-fold (p<0.01), progesterone 2-fold (p<0.05), and corticosterone 4.9-fold (p<0.01); it also increased FZ area (SPARC+ and CYP17A1+, both 3.5-fold) and decreased DZ area (NCAM-1+, 1.9-fold).
- Ketoconazole (10 µM) after 14 days decreased androstenedione 1.8-fold (p<0.05) and DHEAS 4.2-fold (p<0.01), while increasing 11-deoxycortisol 4.3-fold (p<0.01), 17-hydroxyprogesterone 2.3-fold (p<0.05), and progesterone 11.2-fold (p<0.01); no effect on FZ/DZ area or cell viability was observed.
Methods
- Human adrenal tissue from 54 first-trimester fetuses (59 adrenals; GW 8–11) was collected after elective surgical termination; 8 intact adrenals from independent fetuses served as non-culture controls. Tissue was divided into ~1 mm³ fragments and cultured in hanging drops in 40 µL medium for 7 or 14 days, with complete medium change every 48 hours.
- Treatments were ACTH (1 nM) or ketoconazole (10 µM) versus vehicle; each adrenal was divided so equal halves were used for vehicle and treatment.
- Validation included immunohistochemistry for CYP17A1, SPARC, NCAM-1, SF-1, BrdU, and cPARP, plus liquid chromatography-tandem mass spectrometry (LC-MS/MS) for steroid metabolites in pooled culture media. Statistics used Mann Whitney (two-tailed) U-test for 7- vs 14-day comparisons and Wilcoxon signed rank test (two-tailed) for treatment vs vehicle.
Limitations
- Stated: zone-specific immunohistochemistry results should be considered semi-quantitative because paraffin-embedded cultured fragments varied in orientation; a small sub-population lost FZ/DZ markers and SF-1; ketoconazole’s lack of effect on cortisol was unexpected, and the 10 µM dose is lower than expected in vivo serum concentrations; comparing effects in heterogeneous tissue to previous cell-type- and dose-specific studies is difficult.
- Evident from the text: the model uses normal first-trimester human fetal adrenal tissue (GW 8–11), not CAH tissue or genetically manipulated tissue, so its proposed use as a human CAH ex vivo model is not directly demonstrated.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 16 cited sources checked · 0 supported · 0 flagged
- Findingown data
Cortisol was measured in the second highest concentrations among the measured metabolites, at >1000 nmol/L.
“with cortisol (>1000 nmol/L) measured in the second highest concentrations (after DHEAS)”
Quote in the paperNot a substantial claim - Findingown data
Ketoconazole treatment inhibited androgen secretion in ex vivo cultured human fetal adrenal tissue.
“inhibition of androgen secretion”
- Also stated in: § Steroidogenic activity can be both stimulated and inhibited in HFA tissue cultured ex vivo · plain
“Treatment with ketoconazole resulted in decreased secretion of androstenedione (1.8-fold, p<0.05) and DHEAS (4.2-fold, p<0.01) after culture for 14 days”
Quote in the paperSubstantial claim- Rests on an assumption: The DMSO vehicle at 0.1% does not affect human fetal adrenal tissue steroidogenesis or viability.
- Also stated in: § Steroidogenic activity can be both stimulated and inhibited in HFA tissue cultured ex vivo · plain
- Findingown data
The ex vivo culture approach preserved cell populations of all fetal adrenal zones.
“preserved cell populations of all fetal adrenal zones”
- Also stated in: § Ex vivo culture preserves HFA tissue morphology and cell viability · plain
“The overall morphology of the cultured HFA fragments was maintained preserving both the DZ and FZ after both culture periods”
- Also stated in: § Steroidogenic activity is maintained after ex vivo culture of HFA tissue · plain
“Overall, the zonation of the ex vivo cultured tissue was preserved containing both FZ cells (SPARC + , (21)) and DZ cells (NCAM-1 + , ( 45))”
Quote in the paperSubstantial claim - Also stated in: § Ex vivo culture preserves HFA tissue morphology and cell viability · plain
- Findingown data
The ex vivo culture approach maintained cell viability of human fetal adrenal tissue.
“The culture approach maintained cell viability”
- Also stated in: § Ex vivo culture preserves HFA tissue morphology and cell viability · plain
“Overall, only few cPARP + cells were detected in both cultured and non-culture control HFA tissue”
Quote in the paperSubstantial claim - Also stated in: § Ex vivo culture preserves HFA tissue morphology and cell viability · plain
- Findingown data
The zonation of the ex vivo cultured human fetal adrenal tissue was preserved containing both fetal zone (FZ) and definitive zone (DZ) cells.
“Overall, the zonation of the ex vivo cultured tissue was preserved containing both FZ cells (SPARC + , (21)) and DZ cells (NCAM-1 + , ( 45))”
Quote in the paperSubstantial claim
- Findingown data
Treatment with ACTH and ketoconazole did not alter the overall morphology of the ex vivo cultured human fetal adrenal tissue.
“Treatment with ACTH and ketoconazole did not alter the overall morphology of the ex vivo cultured HFA tissue, which still contained all cell populations present in 1 st trimester HFA tissue at the end of the culture period.”
Quote in the paperSubstantial claim - Findingown data
The most pronounced effects on steroid hormone production in ex vivo cultured human fetal adrenal tissue were seen after 14 days of culture for both ACTH and ketoconazole treatments.
“Overall, the most pronounced effects on steroid hormone production were seen after 14 days of culture for both ACTH and ketoconazole treatments.”
Quote in the paperSubstantial claim - Findingown data
ACTH treatment of ex vivo cultured human fetal adrenal tissue decreased definitive zone (DZ) area (NCAM-1+, 1.9-fold, p<0.05) after 14 days.
“as well as a decreased DZ-area (NCAM-1 + , 1.9-fold, p<0.05), compared with vehicle controls after 14 days of culture”
Quote in the paperSubstantial claim - Findingown data
The ex vivo culture approach preserved human fetal adrenal tissue morphology.
“The overall morphology of the cultured HFA fragments was maintained preserving both the DZ and FZ after both culture periods”
- Also stated in: § Discussion · plain
“Overall, the presented HFA ex vivo culture approach preserved cell viability and an overall tissue zonation that consisted of both neuroendocrine and steroidogenic cells.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
ACTH treatment of ex vivo cultured human fetal adrenal tissue increased steroidogenic intermediates progesterone (2-fold, p<0.05) and corticosterone (4.9-fold, p<0.01).
“The steroidogenic intermediates progesterone (2-fold, p<0,05) and corticosterone (4.9-fold, p<0.01) levels were also increased compared with vehicle controls.”
Quote in the paperSubstantial claim - Findingown data
Proliferating cells were more frequently observed in definitive zone (DZ) cells in ex vivo cultured human fetal adrenal samples regardless of treatment.
“Proliferating cells were more frequently observed in DZ cells in ex vivo cultured samples regardless of treatment but were also observed in FZ and neural crest cells in accordance with non-culture controls”
Quote in the paperNot a substantial claim - Findingown data
The cultured human fetal adrenal tissue produced high amounts of both androgens and glucocorticoids.
“The cultured HFA tissue produced high amounts of both androgens and glucocorticoids.”
Quote in the paperSubstantial claim - Findingown data
The ex vivo culture approach resulted in a low level of apoptosis in human fetal adrenal tissue.
“Overall, only few cPARP + cells were detected in both cultured and non-culture control HFA tissue”
- Also stated in: § Ex vivo culture preserves HFA tissue morphology and cell viability · plain
“A small increase in the prevalence of cPARP + cells/mm 2 was observed in cultured tissue compared with non-culture control HFA tissue, but the number of cPARP + cells/mm 2 decreased with length of culture period (3.8-fold, p<0.05) when HFA tissue cultured for 14-days were compared to 7-days”
Quote in the paperSubstantial claim - Also stated in: § Ex vivo culture preserves HFA tissue morphology and cell viability · plain
- Findingown data
There was a 1.5-fold decrease in tissue positive for human fetal adrenal zonation markers in cultured tissue compared with non-culture controls.
“few areas of the cultured tissue fragments appeared negative for DZ or FZ markers resulting in a 1.5-fold decrease (p<0.05) in tissue positive for the HFA zonation markers compared with non-culture controls”
Quote in the paperNot a substantial claim- Rests on an assumption: The non-culture control human fetal adrenal tissue represents the normal in vivo state of human fetal adrenal tissue.
- Findingown data
The reduction in human fetal adrenal zonation markers did not depend on the culture period.
“This reduction did not appear to be dependent on the culture period as no differences were observed between CYP17A1, SPARC or NCAM-1 expression between tissue fragments cultured for 7-and 14-days”
Quote in the paperNot a substantial claim - Findingown data
Ketoconazole treatment of ex vivo cultured human fetal adrenal tissue had no effect on fetal zone (FZ) area or definitive zone (DZ) area after 7 or 14 days.
“In contrast, no effect on FZ-area (SPARC + , CYP17A1 + ) or DZ-area (NCAM-1 + ) was observed after 7-or 14-days culture with ketoconazole treatment”
Quote in the paperSubstantial claim- Rests on an assumption: The DMSO vehicle at 0.1% does not affect human fetal adrenal tissue steroidogenesis or viability.
- Findingown data
ACTH treatment of ex vivo cultured human fetal adrenal tissue increased fetal zone (FZ) area (SPARC+ and CYP17A1+, both 3.5-fold increase, p<0.05 and p<0.01) after 14 days.
“Treatment with ACTH altered the composition of HFA tissue, including an increased FZ-area (SPARC + and CYP17A1 + , both 3.5-fold increase, p<0.05 and p<0.01, respectively)”
Quote in the paperSubstantial claim - Findingown data
DHEAS was the most abundant measured metabolite secreted by cultured human fetal adrenal tissue, at >20,000 nmol/L.
“As anticipated DHEAS were by far the most abundant of all measured metabolites (>20,000 nmol/L).”
Quote in the paperNot a substantial claim - Findingown data
The cultured HFA tissue continued to secrete steroidogenic intermediates, glucocorticoids, and androgens.
“continued secretion of steroidogenic intermediates, glucocorticoids, and androgens”
- Also stated in: § Steroidogenic activity is maintained after ex vivo culture of HFA tissue · plain
“the secretion of androgens, glucocorticoids, and steroidogenic intermediates was consistent with no differences in culture media concentrations between 7-and 14-days cultures”
Quote in the paperSubstantial claim - Also stated in: § Steroidogenic activity is maintained after ex vivo culture of HFA tissue · plain
- Findingown data
ACTH treatment stimulated steroidogenesis in ex vivo cultured human fetal adrenal tissue.
“Adrenocorticotropic hormone (ACTH) and ketoconazole treatment of ex vivo cultured human fetal adrenal tissue resulted in the stimulation of steroidogenesis and inhibition of androgen secretion, respectively”
- Also stated in: § Steroidogenic activity can be both stimulated and inhibited in HFA tissue cultured ex vivo · plain
“ACTH-treatment increased androgen, glucocorticoid, and steroidogenic intermediates metabolite concentrations significantly compared with vehicle control treated samples after both culture periods”
Quote in the paperSubstantial claim - Also stated in: § Steroidogenic activity can be both stimulated and inhibited in HFA tissue cultured ex vivo · plain
- Findingown data
Ketoconazole treatment of ex vivo cultured human fetal adrenal tissue decreased androstenedione (1.8-fold, p<0.05) and DHEAS (4.2-fold, p<0.01) after 14 days.
“Treatment with ketoconazole resulted in decreased secretion of androstenedione (1.8-fold, p<0.05) and DHEAS (4.2-fold, p<0.01) after culture for 14 days”
Quote in the paperSubstantial claim- Rests on an assumption: The DMSO vehicle at 0.1% does not affect human fetal adrenal tissue steroidogenesis or viability.
- Findingown data
The ex vivo culture approach maintained cell proliferation in human fetal adrenal tissue.
“The applied ex vivo culture approach supported continued cell proliferation as determined by BrdU (Figure 1c) and Ki67 expression”
- Also stated in: § Ex vivo culture preserves HFA tissue morphology and cell viability · boosted
“Quantification of BrdU + cells demonstrated no difference in the number of proliferating (BrdU + cells) between 7-and 14-days culture”
Quote in the paperSubstantial claim - Also stated in: § Ex vivo culture preserves HFA tissue morphology and cell viability · boosted
- Findingown data
No significant effects were detected on the number of proliferating (BrdU+) or apoptotic (cPARP+) cells in ex vivo cultured human fetal adrenal tissue after treatment with ACTH or ketoconazole compared with vehicle controls.
“No significant effects were detected on the number of proliferating (BrdU + ) or apoptotic (cPARP + ) cells after treatment with ACTH or ketoconazole compared with vehicle controls”
Quote in the paperSubstantial claim- Rests on an assumption: The DMSO vehicle at 0.1% does not affect human fetal adrenal tissue steroidogenesis or viability.
- Findingown data
ACTH treatment of ex vivo cultured human fetal adrenal tissue increased glucocorticoid levels after 14 days, including 17-hydroxyprogesterone (4.5-fold, p<0.01), 11-deoxycortisol (12.7-fold, p<0.01), cortisol (6.9-fold, p<0.01) and cortisone (1.7-fold, p<0.01).
“Also, glucocorticoid levels were increased after 14 days ACTH stimulation, including 17-hydroxyprogesterone (4.5-fold, p<0.01), 11-deoxycortisol (12.7-fold, p<0.01), cortisol (6.9-fold, p<0.01) and cortisone (1.7-fold, p<0.01).”
Quote in the paperSubstantial claim - Findingown data
ACTH treatment of ex vivo cultured human fetal adrenal tissue increased androgen levels after 14 days, including androstenedione (10.8-fold, p<0.01), testosterone (9.4-fold, p<0.05) and DHEAS (2.5-fold, p<0.01).
“After 14 days of culture, ACTH treatment resulted in increased androgen levels, including androstenedione (10.8-fold, p<0.01), testosterone (9.4-fold, p<0.05) and DHEAS (2.5-fold, p<0.01).”
Quote in the paperSubstantial claim - Findingcitation
ACTH stimulated the secretion of all measured metabolites in ex vivo cultured human fetal adrenal tissue.
“ACTH stimulated the secretion of all measured metabolites, which is in accordance with previous studies showing a stimulating effect on both cortisol, DHEAS, androstenedione and testosterone (9,30,31,39).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [9] Goto, 2006, In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development, J Clin Invest. source
Not checked in the free run.
- cites [30] Goodyer, 1977, Exploration of the human fetal pituitary adrenal axis: stimulation of cortisol and dehydroepiandrosterone sulfate biosynthesis by homologous pituitary in organ culture, Steroids. source
Not checked in the free run.
- cites [31] Branchaud, 1978, Steroidogenic activity of hACTH and related peptides on the human neocortex and fetal adrenal cortex in organ culture, Steroids. source
Not checked in the free run.
- Findingcitation
The high DHEAS levels secreted from the cultured human fetal adrenal tissue are in accordance with DHEAS being the most abundant adrenal hormone produced during fetal life.
“Additionally, the high DHEAS levels secreted from the cultured HFA tissue in this study is in accordance with DHEAS being the most abundant adrenal hormone produced during fetal life (52).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Quinn, 2018, DHEA in prenatal and postnatal life: implications for brain and behavior, Vitam Horm. source
Not checked in the free run.
- Findingcitation
The secreted steroid hormone profiles of androgens, glucocorticoids and steroidogenic intermediates from the cultured human fetal adrenal tissue are in accordance with the intra-adrenal metabolites previously measured in un-cultured 1st trimester human fetal adrenal samples.
“The secreted steroid hormone profiles of androgens, glucocorticoids and steroidogenic intermediates from the cultured tissue is in accordance with the intra-adrenal metabolites previously measured in un-cultured 1 st trimester HFA samples (5).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Melau, 2019, Characterization of human adrenal steroidogenesis during fetal development, J Clin Endocrinol Metab. source
Not checked in the free run.
- Rests on an assumption: The non-culture control human fetal adrenal tissue represents the normal in vivo state of human fetal adrenal tissue.
- Findingcitation
The continued production of androgens and glucocorticoids in this study contrasts with previous long-term human fetal adrenal tissue cultures, which showed a rapid time-dependent decrease in the production of both DHEAS and cortisol.
“The continued production of androgens and glucocorticoids reported in this study contrasts with previous long-term HFA tissue cultures which showed a rapid time-dependent decrease in the production of both DHEAS and cortisol (30).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] Goodyer, 1977, Exploration of the human fetal pituitary adrenal axis: stimulation of cortisol and dehydroepiandrosterone sulfate biosynthesis by homologous pituitary in organ culture, Steroids. source
Not checked in the free run.
- Findingown data
Stimulation of steroid hormone secretion in ex vivo cultured human fetal adrenal tissue was accompanied by an increased fetal zone (FZ) area and CYP17A1 expression after culture for 14 days.
“Interestingly, stimulation of steroid hormone secretion was accompanied by an increased FZ area and CYP17A1 expression after culture for 14 days.”
Quote in the paperSubstantial claim - Findingown data
The ex vivo culture approach described in this study supports the endocrine function of the human fetal adrenal tissue.
“The ex vivo culture approach described in this study supports the endocrine function of the HFA tissue.”
Quote in the paperSubstantial claim - Findingown data
Ketoconazole treatment did not affect expression of CYP17A1 in cultured HFA tissue compared with vehicle controls.
“In this study, ketoconazole treatment did not affect FZ-area (SPARC expression), expression of CYP17A1 in the cultured tissue or cell viability compared with vehicle controls.”
Quote in the paperSubstantial claim- Rests on an assumption: The measured steroid metabolite concentrations in culture media reflect adrenal steroidogenesis in the cultured tissue.
- Findingreasoning
Ketoconazole treatment for 14 days inhibited secretion of androstenedione and DHEAS in HFA ex vivo cultures.
“The observed inhibition of the HFA androgens androstenedione and DHEAS following ketoconazole treatment for 14 days was therefore expected”
Quote in the paperSubstantial claim- Rests on an assumption: The measured steroid metabolite concentrations in culture media reflect adrenal steroidogenesis in the cultured tissue.
- Findingown data
Ketoconazole treatment did not affect FZ-area (SPARC expression) in cultured HFA tissue compared with vehicle controls.
“In this study, ketoconazole treatment did not affect FZ-area (SPARC expression), expression of CYP17A1 in the cultured tissue or cell viability compared with vehicle controls.”
Quote in the paperSubstantial claim- Rests on an assumption: The measured steroid metabolite concentrations in culture media reflect adrenal steroidogenesis in the cultured tissue.
- Findingreasoning
Ketoconazole treatment for 14 days increased levels of progesterone and 17-hydroxyprogesterone in HFA ex vivo cultures.
“as was the increased levels of substrates for affected enzymes such as progesterone and 17-hydroxyprogesterone.”
Quote in the paperSubstantial claim- Rests on an assumption: The measured steroid metabolite concentrations in culture media reflect adrenal steroidogenesis in the cultured tissue.
- Findingown data
Ketoconazole treatment did not affect cell viability in cultured HFA tissue compared with vehicle controls.
“In this study, ketoconazole treatment did not affect FZ-area (SPARC expression), expression of CYP17A1 in the cultured tissue or cell viability compared with vehicle controls.”
Quote in the paperSubstantial claim- Rests on an assumption: The measured steroid metabolite concentrations in culture media reflect adrenal steroidogenesis in the cultured tissue.
- Findingnone given
Higher prevalence of 3βHSD2+ cells/tissue area in 1st trimester compared with 2nd trimester HFA tissues.
“The higher prevalence of 3βHSD2 + cells/tissue area in 1 st trimester compared with 2 nd trimester HFA tissues”
Quote in the paperSubstantial claim - Findingown data
Ketoconazole treatment had no effect on cortisol secretion in HFA ex vivo cultures compared with vehicle controls.
“especially the lack of effect on cortisol secretion when compared with vehicle control samples.”
Quote in the paperSubstantial claim- Rests on an assumption: The measured steroid metabolite concentrations in culture media reflect adrenal steroidogenesis in the cultured tissue.
- Findingown data
Ketoconazole treatment had no overall effect on corticosteroid levels in HFA ex vivo cultures compared with vehicle controls.
“The overall lack of ketoconazole-mediated effects on corticosteroid levels was unexpected”
Quote in the paperSubstantial claim- Rests on an assumption: The measured steroid metabolite concentrations in culture media reflect adrenal steroidogenesis in the cultured tissue.
- Findingown data
Ketoconazole treatment increased the concentration of 11-deoxycortisol in HFA ex vivo cultures.
“However, the increased concentration of 11-deoxycortisol indicates that if the system had been pushed further either by initial ACTH stimulation or higher ketoconazole concentrations an effect on cortisol might have been detectable.”
Quote in the paperNot a substantial claim- Rests on an assumption: The measured steroid metabolite concentrations in culture media reflect adrenal steroidogenesis in the cultured tissue.
- Findingcitation
No effects were observed in ex vivo cultured HFA tissue following treatment with 1 μM ketoconazole.
“Accordingly, no effects were observed in the ex vivo cultured HFA tissue following treatment with 1 µM ketoconazole (Supplementary figure 5 (59))”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Melau
Not checked in the free run.
- Rests on an assumption: The measured steroid metabolite concentrations in culture media reflect adrenal steroidogenesis in the cultured tissue.
- Findingown data
Migrating neural crest cells were frequently observed in ex vivo cultured HFA tissue, similar to non-cultured control tissue.
“Migrating neural crest cells were frequently observed in ex vivo cultured tissue similar to non-cultured control tissue.”
Quote in the paperNot a substantial claim - Interpretationown data
The treatment response of ex vivo cultured human fetal adrenal tissue was treatment-specific.
“demonstrating a treatment-specific response”
Quote in the paperSubstantial claim - Interpretationown data
Ex vivo culture of human fetal adrenal tissue constitutes a novel approach to investigate local effects of pharmaceutical exposures or emerging therapeutic options targeting imbalanced steroidogenesis in adrenal disorders including CAH.
“Together these data indicate that ex vivo culture of human fetal adrenal tissue constitutes a novel approach to investigate local effects of pharmaceutical exposures or emerging therapeutic options targeting imbalanced steroidogenesis in adrenal disorders including CAH.”
Quote in the paperSubstantial claim- Rests on an assumption: The development and endocrine function of human fetal adrenals are still relatively unexplored.
- Interpretationown data
The ex vivo culture approach recapitulated de novo adrenal steroidogenesis based on continued secretion of steroidogenic intermediates, glucocorticoids, and androgens.
“recapitulated de novo adrenal steroidogenesis based on continued secretion of steroidogenic intermediates, glucocorticoids, and androgens”
Quote in the paperSubstantial claim- Rests on an assumption: Continued secretion of steroid hormones by cultured human fetal adrenal tissue over 14 days reflects de novo steroidogenesis rather than release of pre-formed steroids.
- Interpretationown data
The ex vivo culture approach provides proof-of-principle that it can be used in future studies to examine effects on adrenal function following specific treatments.
“Thus, this provides proof-of-principle that this culture approach can be used in future studies to examine effects on adrenal function following specific treatments.”
Quote in the paperSubstantial claim - Study design and conductreasoning
At least some of the difference in the quantification of zonation-area was due to the variation in orientation of the paraffin embedded cultured tissue fragments.
“At least some of the difference in the quantification of zonation-area was due to the variation in orientation of the paraffin embedded cultured tissue fragments.”
Quote in the paperNot a substantial claim - Interpretationcitation
The enlarged fetal zone (FZ) in ACTH stimulated tissue found in the present study after both 7 and 14 days treatment could also explain the tendency towards a decreased number of proliferating cells, since definitive zone (DZ) cells are known to have a higher proliferation rate than FZ cells.
“The enlarged FZ in ACTH stimulated tissue found in the present study after both 7and 14-days treatment could also explain the tendency towards a decreased number of proliferating cells since DZ cells are known to have a higher proliferation rate than FZ cells (25).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Ishimoto, 2008, The periphery of the human fetal adrenal gland is a site of angiogenesis: zonal differential expression and regulation of angiogenic factors, J Clin Endocrinol Metab. source
Not checked in the free run.
- Interpretationown data
The ex vivo culture approach allows inhibition and stimulation of human fetal adrenal tissue steroidogenic activity.
“Additionally, we demonstrated that this culture approach allows inhibition and stimulation of the HFA tissues steroidogenic activity.”
Quote in the paperSubstantial claim - Interpretationreasoning
Tissue fragments of approximately 1 mm3 used in this study seem to allow diffusion of oxygen into the core of the fragments, protecting the tissue from necrosis.
“Thus, tissue fragments of approximately 1 mm 3 used in this study seems to allow diffusion of oxygen into the core of the fragments protecting the tissue from necrosis.”
Quote in the paperSubstantial claim - Premisecitation
Administration of 400-1200 mg/day ketoconazole corresponds to ~12-25 μM serum ketoconazole detected in patients 4-6 h after drug intake.
“corresponding to ~12-25 µM serum-ketoconazole detected in patients 4-6 h after drug intake (61).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] Sugar, 1987, Pharmacology and toxicity of high-dose ketoconazole, Antimicrob Agents Chemother. source
Not checked in the free run.
- Interpretationcitation
The used dose of 10 μM ketoconazole in this study is lower than expected in vivo ketoconazole serum concentrations in patients.
“the used dose of 10 µM ketoconazole in this study is lower than expected in vivo ketoconazole serum concentrations in patients”
Quote in the paperSubstantial claim - Interpretationown data
Signaling pathways involved in the regulation of adrenal steroidogenesis are kept intact in ex vivo cultured HFA tissue.
“Together these data suggest that signaling pathways involved in the regulation of adrenal steroidogenesis are kept intact in the ex vivo cultured tissue”
Quote in the paperSubstantial claim - Premisecitation
Intra-adrenal concentrations of corticosteroids are similar between 1st and 2nd trimester HFA tissues.
“similar intra-adrenal concentrations of corticosteroids (5)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Melau, 2019, Characterization of human adrenal steroidogenesis during fetal development, J Clin Endocrinol Metab. source
Not checked in the free run.
- Premisecitation
Ketoconazole has different IC50 values for each steroidogenic enzyme.
“Ketoconazole has different IC50 values for each steroidogenic enzyme (58)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Fleseriu, 2016, Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies, Pituitary. source
Not checked in the free run.
- Interpretationreasoning
Manipulations of specific steroidogenic enzymes and cofactors in the HFA ex vivo culture model can serve as the foundation of a human CAH ex vivo culture model for mechanistic studies of dysregulated steroidogenesis in CAH.
“Additionally, manipulations of specific steroidogenic enzymes and cofactors in this model can serve as the foundation of a human CAH ex vivo culture model allowing mechanistic studies of the dysregulated steroidogenesis in this rare disease.”
Quote in the paperSubstantial claim- Rests on an assumption: The ex vivo HFA culture model's responses to ACTH and ketoconazole are representative of in vivo human fetal adrenal responsiveness.
- Interpretationreasoning
The HFA ex vivo culture model can be used to investigate local effects of pharmaceutical exposures or emerging therapeutic treatments that may impact adrenal development or function during pregnancy.
“This specific steroidogenic response in the presented HFA ex vivo cultured tissue suggest that this model can be used to investigate local effects of pharmaceutical exposures or emerging therapeutic treatments that may impact adrenal development or function during pregnancy.”
Quote in the paperSubstantial claim- Rests on an assumption: The ex vivo HFA culture model's responses to ACTH and ketoconazole are representative of in vivo human fetal adrenal responsiveness.
- Interpretationreasoning
The ex vivo cultured HFA tissue retains the capacity to respond to both ACTH stimulation and ketoconazole inhibition for up to 14 days.
“which retains the capacity to respond to both ACTH stimulation and ketoconazole inhibition for up to 14 days.”
- Also stated in: § Discussion · boosted
“Investigations of treatment effects in the HFA ex vivo cultures have demonstrated a specific response to both stimulation and inhibition.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · boosted
- May combine two claims. 13
- Classified as probably not a substantial claim. 10
May combine two claims.
Findingown dataKetoconazole treatment of ex vivo cultured human fetal adrenal tissue increased 11-deoxycortisol (4.3-fold, p<0.01), 17-hydroxyprogesterone (2.3-fold, p<0.05) and progesterone (11.2-fold, p<0.01).
“Additionally, levels of 11-deoxycortisol (4.3-fold, p<0.01), 17-hydroxyprogesterone (2.3-fold, p<0.05) and progesterone (11.2-fold, p<0.01) were all increased compared with vehicle controls as a result of ketoconazole treatment”
Quote in the paperSubstantial claim- Rests on an assumption: The DMSO vehicle at 0.1% does not affect human fetal adrenal tissue steroidogenesis or viability.
May combine two claims.
Findingown dataTestosterone levels were the lowest among the measured androgens but were detectable in all samples, at <5 nmol/L.
“testosterone (<5 nmol/L) levels were the lowest among the measured androgens but were still detectable in all samples”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe presented human fetal adrenal ex vivo culture approach preserved cell viability and an overall tissue zonation that consisted of both neuroendocrine and steroidogenic cells.
“Overall, the presented HFA ex vivo culture approach preserved cell viability and an overall tissue zonation that consisted of both neuroendocrine and steroidogenic cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe ex vivo culture approach preserved 1st trimester human fetal adrenal morphology, maintaining both fetal zone (FZ), definitive zone (DZ) and migrating neuroendocrine cells.
“In addition to continued proliferation, the ex vivo culture approach used here preserved 1 st trimester HFA morphology maintaining both FZ, DZ and migrating neuroendocrine cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAn ex vivo culture approach for HFA tissue has been established that allows culture for two weeks with preserved adrenal morphology, cell viability, and continued high steroidogenic activity.
“In conclusion, we have established an ex vivo culture approach for HFA tissue that allows culture for two weeks with preserved adrenal morphology, cell viability, and a continued high steroidogenic activity.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe applied ex vivo culture approach supports HFA tissue for up to 14 days of culture with overall preserved morphology, continued cell proliferation and a low level of apoptosis.
“Together these results suggest that the applied ex vivo culture approach supports HFA tissue for up to 14-days of culture with overall preserved morphology, continued cell proliferation and a low level of apoptosis in the tissue.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe presented human fetal adrenal ex vivo approach maintains a high steroidogenic activity, which is a unique advance of this experimental approach, while also preserving fetal zone-specific abundant expression of steroidogenic enzymes.
“Thus, the presented HFA ex vivo approach maintains a high steroidogenic activity which is a unique advance of this experimental approach while also preserving FZ-specific abundant expression of steroidogenic enzymes.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataNegative controls were included in immunohistochemistry and processed with the primary antibody replaced by the dilution buffer alone, none of which showed staining.
“Negative controls were included and processed with the primary antibody replaced by the dilution buffer alone, none of which showed staining.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationEx vivo cultured human fetal adrenal tissue responds in a similar manner to human fetal adrenal tissue in vivo, as enlargement of the steroidogenic adrenal cortex is known to be a consequence of hyperstimulated adrenals.
“This suggests that ex vivo cultured tissue responds in a similar manner to HFA tissue in vivo as enlargement of the steroidogenic adrenal cortex is known to be a consequence of hyperstimulated adrenals (57).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] White, 2000, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Endocr Rev.
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenThe clinically validated analysis package included estrone sulfate, testosterone, androstenedione, DHEAS, cortisone, cortisol, 11-deoxycortisol, 17-hydroxyprogesterone, corticosterone, and progesterone.
“This clinically validated analysis package included estrone sulfate, testosterone, androstenedione, DHEAS, cortisone, cortisol, 11deoxycortisol, 17-hydroxyprogesterone, corticosterone, and progesterone.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningTo ensure an equal relative ratio of definitive zone (DZ) vs fetal zone (FZ) cells prior to the experimental vehicle vs. treatment set-up, the adrenal gland was initially divided into two halves prior to division into 1 mm3 fragments.
“To ensure an equal relative ratio of DZ vs FZ cells were equal prior to the experimental vehicle vs. treatment set-up, the adrenal gland was initially divided into two halves prior to division into 1 mm 3 fragments.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationSteroid hormone levels in culture media were measured using a method established to quantify steroid metabolites in serum by isotype-dilution TurboFlow-LC-MS/MS as previously described.
“Steroid hormone levels were measured using a method established to quantify steroid metabolites in serum by isotype-dilution TurboFlow-LC-MS/MS as previously described (42).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] Søeborg, 2017, Isotope-dilution TurboFlow-LC-MS/MS method for simultaneous quantification of ten steroid metabolites in serum, Clin Chim Acta. source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningConserved cross-talk between the different adrenal cell-types is central in the establishment of a culture model that aims to recapitulate normal and dysregulated human fetal adrenal development and function.
“Thus, conserved cross-talk between the different adrenal cell-types are central in the establishment of a culture model that aims to recapitulate normal and dysregulated HFA development and function.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataFor the four analytical batches included in this study, the relative standard deviation (RSD) was < 10% for all steroids in culture media controls spiked in low level, except for estrone sulfate and DHEAS (< 17%), and < 4.2% for all steroids in controls spiked in high level.
“For the four analytical batches included in this study the relative standard deviation (RSD) were < 10% for all steroids in culture media controls spiked in low level, except for estrone sulfate and DHEAS (< 17%), and < 4.2% for all steroids in controls spiked in high level.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe higher prevalence of 3βHSD2+ cells in 1st trimester and similar intra-adrenal corticosteroid concentrations suggest an elevated capacity for glucocorticoid synthesis and a lower sensitivity towards inhibition of corticosteroid biosynthesis in 1st trimester adrenal tissue.
“could suggest an elevated capacity for glucocorticoid synthesis and subsequently a lower sensitivity towards inhibition of corticosteroid biosynthesis in 1 st trimester adrenal tissue.”
Quote in the paperSubstantial claim- Rests on an assumption: The gestational age of HFA tissue (1st vs 2nd trimester) does not confound the effects of ketoconazole treatment.
Classified as probably not a substantial claim.
PremisecitationKetoconazole is normally administered in doses between 400-1200 mg/day.
“ketoconazole normally is administrated in doses between 400-1200 mg/day (60)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Braun, 2020, What is the role of medical therapy in adrenal-dependent Cushing’s syndrome?, Best Pract Res Clin Endocrinol Metab. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataThe increased 11-deoxycortisol concentration indicates that if the system had been pushed further by initial ACTH stimulation or higher ketoconazole concentrations, an effect on cortisol might have been detectable.
“However, the increased concentration of 11-deoxycortisol indicates that if the system had been pushed further either by initial ACTH stimulation or higher ketoconazole concentrations an effect on cortisol might have been detectable.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIn a system where steroidogenesis is not completely inhibited, some metabolites are expected to be upregulated while metabolites downstream of enzymes with the lowest IC50 values are expected to be downregulated.
“therefore some metabolites are expected to be upregulated while metabolites downstream of these enzymes with the lowest IC50 values are expected to be downregulated in a system where steroidogenesis is not completely inhibited.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationKetoconazole concentrations below 10 μM did not reduce cell viability of human adrenal carcinoma cells.
“This is in line with a previous study which found ketoconazole concentrations below 10 µM did not reduce cell viability of human adrenal carcinoma cells (61).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Sugar, 1987, Pharmacology and toxicity of high-dose ketoconazole, Antimicrob Agents Chemother. source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationKetoconazole affects multiple steps of adrenal steroidogenesis.
“Effects of the well-known inhibitor of steroidogenic enzymes, ketoconazole which affects multiple steps of adrenal steroidogenesis was also examined in the HFA ex vivo model.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Fleseriu, 2016, Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies, Pituitary. source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
Study design and conductreasoningZone-specific immunohistochemistry results should be considered as semi-quantitative.
“Therefore, zone-specific IHC results should be considered as semi-quantitative.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe HFA ex vivo culture model may be used to study both normal and dysregulated HFA steroidogenic activity and function, which is relevant for understanding development and management of adrenal disorders in humans.
“Therefore, this model may be used to study both normal and dysregulated HFA steroidogenic activity and function, which will be of particular relevance for understanding development and management of adrenal disorders in humans.”
Quote in the paperSubstantial claim- Rests on an assumption: The ex vivo HFA culture model's responses to ACTH and ketoconazole are representative of in vivo human fetal adrenal responsiveness.
The paper relies on this without support.
Continued secretion of steroid hormones by cultured human fetal adrenal tissue over 14 days reflects de novo steroidogenesis rather than release of pre-formed steroids.
“recapitulated de novo adrenal steroidogenesis based on continued secretion of steroidogenic intermediates, glucocorticoids, and androgens”
The paper relies on this without support.
The DMSO vehicle at 0.1% does not affect human fetal adrenal tissue steroidogenesis or viability.
“ketoconazole dissolved in dimethyl sulfoxide vehicle (DMSO, 0.1 %)”
The paper relies on this without support.
The development and endocrine function of human fetal adrenals are still relatively unexplored.
“Despite the importance of steroids secreted by human fetal adrenals (HFA) the development and endocrine function of these organs are still relatively unexplored.”
The paper relies on this without support.
The non-culture control human fetal adrenal tissue represents the normal in vivo state of human fetal adrenal tissue.
“Additionally, 8 intact adrenals from independent fetuses were formalin fixed immediately after dissection and used as non-culture controls.”
The paper relies on this without support.
The ex vivo HFA culture model's responses to ACTH and ketoconazole are representative of in vivo human fetal adrenal responsiveness.
“This specific steroidogenic response in the presented HFA ex vivo cultured tissue suggest that this model can be used to investigate local effects of pharmaceutical exposures or emerging therapeutic treatments that may impact adrenal development or function during pregnancy.”
The paper relies on this without support.
The gestational age of HFA tissue (1st vs 2nd trimester) does not confound the effects of ketoconazole treatment.
“The higher prevalence of 3βHSD2 + cells/tissue area in 1 st trimester compared with 2 nd trimester HFA tissues and similar intra-adrenal concentrations of corticosteroids (5) could suggest an elevated capacity for glucocorticoid synthesis and subsequently a lower sensitivity towards inhibition of corticosteroid biosynthesis in 1 st trimester adrenal tissue.”
The paper relies on this without support.
The measured steroid metabolite concentrations in culture media reflect adrenal steroidogenesis in the cultured tissue.
“Secretion of adrenal steroid metabolites was measured by LC-MS/MS in the culture media collected throughout the experimental period of 7-(b,c) or 14-days (d,e).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hanging drop organ cultures maintain in vitro the differentiated function of HFA, recapitulating the expression of zonal markers and the production of a variety of steroids.
“Hanging drop organ cultures are able to maintain in vitro the differentiated function of HFA, recapitulating the expression of zonal markers and the production of a variety of steroids 16 .”
From ACTH and prolactin synergistically and selectively regulate CYP17 expression and adrenal androgen production in human foetal adrenal organ cultures (2023) · cites this paper as [16]
Our data differ from the results reported in the Melau et al. study regarding the effect of ACTH alone on steroid levels in HFA organ cultures.
“However, our data differ from the results reported in the Melau et al . study 16 , which showed that ACTH alone was able to increase the levels of all measured steroids (including DHEAS and ∆ 4-androstenedione) in HFA organ cultures using the same hanging drop system we used in our study.”
From ACTH and prolactin synergistically and selectively regulate CYP17 expression and adrenal androgen production in human foetal adrenal organ cultures (2023) · cites this paper as [16]
The Melau et al. study showed that ACTH alone was able to increase the levels of all measured steroids (including DHEAS and ∆4-androstenedione) in HFA organ cultures using the same hanging drop system.
“However, our data differ from the results reported in the Melau et al . study 16 , which showed that ACTH alone was able to increase the levels of all measured steroids (including DHEAS and ∆ 4-androstenedione) in HFA organ cultures using the same hanging drop system we used in our study.”
From ACTH and prolactin synergistically and selectively regulate CYP17 expression and adrenal androgen production in human foetal adrenal organ cultures (2023) · cites this paper as [16]
Cites
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432 · see citing works
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877 · see citing works
Chen, K., Chen, H., Faas, M. M., de Haan, B. J., Li, J., Xiao, P., Zhang, H., Diana, J., de Vos, P., & Sun, J. T. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201601006 · Cited by 461 · see citing works
Ishimoto, H., & Jaffe, R. B. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0001 · Cited by 379 · see citing works
Embryoid bodies: an in vitro model of mouse embryogenesis
Desbaillets, I., Ziegler, U., Groscurth, P., & Gassmann, M. (2000) · Experimental Physiology · doi:10.1017/s0958067000021047 · Cited by 313 · see citing works
In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development
Goto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25091 · Cited by 284 · see citing works
Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency.
Merke, D. P., Chrousos, G. P., Eisenhofer, G., Weise, M., Keil, M. F., Rogol, A. D., Van Wyk, J. J., & Bornstein, S. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431903 · Cited by 266 · see citing works
Turcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231 · see citing works
Kamrath, C., Hochberg, Z., Hartmann, M. F., Remer, T., & Wudy, S. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1997 · Cited by 191 · see citing works
Development of adrenal cortex zonation
Xing, Y., Lerario, A. M., Rainey, W., & Hammer, G. D. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.001 · Cited by 174 · see citing works
Mazaud‐Guittot, S., Nicolaz, C. N., Lethimonier, C., Coiffec, I., Maamar, M. B., Balaguer, P., Kristensen, D. M., Chevrier, C., Lavoué, V., Poulain, P., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2531 · Cited by 161 · see citing works
Mesiano, S. A., Coulter, C. L., & Jaffe, R. B. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.8077311 · Cited by 133 · see citing works
Pharmacology and toxicity of high-dose ketoconazole
Sugar, A. M., Alsip, S. G., Galgiani, J. N., Graybill, J. R., Dismukes, W. E., Cloud, G. A., Craven, P. C., & Stevens, D. A. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1874 · Cited by 129 · see citing works
Steroid Production by Definitive and Fetal Zones of the Human Fetal Adrenal Gland*
Serón‐Ferré, M., Lawrence, C. C., Siiteri, P. K., & Jaffe, R. B. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-3-603 · Cited by 119 · see citing works
Narasaka, T., Suzuki, T., Moriya, T., & Sasano, H. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00445-7 · Cited by 109 · see citing works
Koike, M., Sakaki, S., Amano, Y., & Kurosawa, H. (2007) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.104.294 · Cited by 98 · see citing works
A Mathematical Model for the Estimation of Human Embryonic and Fetal Age
Evtouchenko, L., Studer, L., Spenger, C., et al. (1996) · Cell Transplantation · doi:10.1177/096368979600500404 · Cited by 95 · see citing works
Jørgensen, A., Young, J., Nielsen, J. E., Joensen, U. N., Toft, B. G., Meyts, E. R., & Loveland, K. L. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.160 · Cited by 94 · see citing works
Self-citationFleseriu, M., & Castinetti, F. (2016) · Pituitary · doi:10.1007/s11102-016-0742-1 · Cited by 87 · see citing works
Jørgensen, A., Nielsen, J. E., Perlman, S., Lundvall, L., Mitchell, R. T., Juul, A., & Meyts, E. R. (2015) · Human Reproduction · doi:10.1093/humrep/dev194 · Cited by 85 · see citing works
Self-citationGuillain–Barré syndrome risk among individuals infected with Zika virus: a multi-country assessment
Mier-y-Terán-Romero, L., Delorey, M. J., Sejvar, J. J., & Johansson, M. A. (2018) · BMC Medicine · doi:10.1186/s12916-018-1052-4 · Cited by 85 · see citing works
ACTH is a Potent Regulator of Gene Expression in Human Adrenal Cells
Xing, Y., Parker, C. R., Edwards, M., & Rainey, W. E. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0006 · Cited by 83 · see citing works
Søeborg, T., Frederiksen, H., Johannsen, T. H., Andersson, A.-M., & Juul, A. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.03.002 · Cited by 83 · see citing works
Self-citationA mathematical model for the estimation of human embryonic and fetal age
Evtouchenko, L. (1996) · Cell Transplantation · doi:10.1016/0963-6897(96)00079-6 · Cited by 81 · see citing works
Abbott, D. H., Zhou, R., Bird, I. M., Dumesic, D. A., & Conley, A. J. (2008) · KARGER eBooks · doi:10.1159/000134831 · Cited by 81 · see citing works
Role of growth factors in the developmental regulation of the human fetal adrenal cortex
Mesiano, S. A., & Jaffe, R. B. (1997) · Steroids · doi:10.1016/s0039-128x(96)00161-4 · Cited by 74 · see citing works
Jones, C. M., Mallappa, A., Reisch, N., Nikolaou, N., Krone, N., Hughes, B. A., O’Neil, D. M., Whitaker, M. J., Tomlinson, J. W., Storbeck, K.-H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2855 · Cited by 74 · see citing works
Creemers, S. G., Feelders, R. A., de Jong, F. H., Franssen, G. J. H., de Rijke, Y. B., van Koetsveld, P. M., & Hofland, L. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00217 · Cited by 73 · see citing works
Alternative pathway androgen biosynthesis and human fetal female virilization
Reisch, N., Taylor, A. E., Nogueira, E. F., Asby, D. J., Dhir, V., Berry, A., Krone, N., Auchus, R. J., Shackleton, C. H. L., Hanley, N. A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906623116 · Cited by 70 · see citing works
Cortical-chromaffin cell interactions in the adrenal gland
Schinner, S., & Bornstein, S. R. (2005) · Endocrine Pathology · doi:10.1385/ep:16:2:091 · Cited by 67 · see citing works
Fluconazole inhibits human adrenocortical steroidogenesis in vitro
van der Pas, R., Hofland, L. J., Hofland, J., TAYLOR, A. E. R., Arlt, W., Steenbergen, J., van Koetsveld, P. M., de Herder, W. W., de Jong, F. H., & Feelders, R. A. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0310 · Cited by 64 · see citing works
Hurtado-Gonzalez, P., Anderson, R. A., Macdonald, J., van den Driesche, S., Kilcoyne, K. R., Jørgensen, A., McKinnell, C., Macpherson, S., Sharpe, R. M., & Mitchell, R. T. (2018) · Environmental Health Perspectives · doi:10.1289/ehp2307 · Cited by 63 · see citing works
Self-citationCoulter, C. L., & Jaffe, R. B. (1998) · Endocrinology · doi:10.1210/endo.139.12.6333 · Cited by 62 · see citing works
Rijk, J. C. W., Peijnenburg, A., Blokland, M., Lommen, A., Hoogenboom, L. A. P., & Bovee, T. F. H. (2012) · Chemical Research in Toxicology · doi:10.1021/tx3001779 · Cited by 62 · see citing works
Sympathoadrenal neural crest cells: The known, unknown and forgotten?
Lumb, R., & Schwarz, Q. (2015) · Development Growth & Differentiation · doi:10.1111/dgd.12189 · Cited by 59 · see citing works
Mesiano, S. A. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.5.1184 · Cited by 54 · see citing works
Branchaud, C. T., Goodyer, C. G., Hall, C. S. G., Arato, J. S., SiliBan, R. E., & Giroud, C. J. P. (1978) · Steroids · doi:10.1016/0039-128x(78)90037-5 · Cited by 53 · see citing works
Jørgensen, A., Macdonald, J., Nielsen, J. E., Kilcoyne, K. R., Perlman, S., Lundvall, L., Thuesen, L. L., Hare, K. J., Frederiksen, H. W., Andersson, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.064 · Cited by 53 · see citing works
Self-citationUpdate on the Corticomedullary Interaction in the Adrenal Gland
Haase, M., Willenberg, H. S., & Bornstein, S. R. (2010) · Endocrine development · doi:10.1159/000321211 · Cited by 49 · see citing works
Characterization of human adrenal steroidogenesis during fetal development
Melau, C., Nielsen, J. E., Frederiksen, H., Kilcoyne, K., Perlman, S., Lundvall, L., Langhoff Thuesen, L., Juul Hare, K., Andersson, A.-M., Mitchell, R. T., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01759 · Cited by 47 · see citing works
Self-citationJohnston, Z. C., Bellingham, M., Filis, P., Soffientini, U., Hough, D., Bhattacharya, S., Simard, M., Hammond, G. L., King, P., O’Shaughnessy, P. J., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1009-7 · Cited by 44 · see citing works
Poli, G., Sarchielli, E., Guasti, D., Benvenuti, S., Ballerini, L., Mazzanti, B., Armignacco, R., Cantini, G., Lulli, M., Chortis, V., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201801028rr · Cited by 43 · see citing works
Jones, C. M., Mallappa, A., Reisch, N., Nikolaou, N., Krone, N. P., Ba, H., O’Neil, D. M., Mj, W., Tomlinson, J. W., K-H, S., et al. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.15.5 · Cited by 41 · see citing works
Decreased adrenomedullary function in infants with classical congenital adrenal hyperplasia.
Kim, M. S., Ryabets-Lienhard, A., Bali, B., Lane, C. J., Park, A. H., Hall, S., & Geffner, M. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1274 · Cited by 38 · see citing works
Rehman, K. S., Sirianni, R., Parker, C. R., Rainey, W. E., & Carr, B. R. (2007) · Reproductive Sciences · doi:10.1177/1933719107307908 · Cited by 36 · see citing works
On behalf of the Study Group Endocrine diseases due to altered function of Gsα protein of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED), SANCTIS, L. D., Giachero, F., Mantovani, G., Weber, G., Salerno, M., Baroncelli, G. I., Elli, F. M., Matarazzo, P., Wasniewska, M. G., et al. (2016) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-016-0310-3 · Cited by 34 · see citing works
Poulsen, K. H., Nielsen, J. E., Frederiksen, H. W., Melau, C., Hare, K. J., Thuesen, L. L., Perlman, S., Lundvall, L., Mitchell, R. T., Juul, A., et al. (2019) · Human Reproduction · doi:10.1093/humrep/dez191 · Cited by 33 · see citing works
Self-citationParlato, R., Otto, C., Tuckermann, J. P., Stotz, S., Kaden, S., Gröne, H., Unsicker, K., & Schütz, G. (2008) · Endocrinology · doi:10.1210/en.2008-1107 · Cited by 32 · see citing works
Temporal and spatial distribution of mast cells and steroidogenic enzymes in the human fetal adrenal
Naccache, A., Louiset, E., Duparc, C., Laquerrière, A., Patrier, S., Renouf, S., Gómez-Sánchez, C. E., Mukai, K., Lefèbvre, H., & Castanet, M. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.06.015 · Cited by 30 · see citing works
Congenital adrenal hyperplasia: phenotype and genotype.
Hughes, I. A. (2002) · PubMed · Cited by 29 · see citing works
Bizzarri, C., Olivini, N., Pedicelli, S., Marini, R., Giannone, G., Cambiaso, P., & Cappa, M. (2016) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-016-0282-3 · Cited by 28 · see citing works
DHEA in prenatal and postnatal life: implications for brain and behavior
Quinn, T., Greaves, R., Badoer, E., & Walker, D. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.03.001 · Cited by 28 · see citing works
Ishimoto, H., Ginzinger, D. G., & Jaffe, R. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2252 · Cited by 27 · see citing works
Muench, M. O., Ratcliffe, J. V., Nakanishi, M., Ishimoto, H., & Jaffe, R. B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030154 · Cited by 21 · see citing works
What is the role of medical therapy in adrenal-dependent Cushing’s syndrome?
Braun, L. T., & Reincke, M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101376 · Cited by 21 · see citing works
Androgenic potential of human fetal adrenals at the end of the first trimester
Savchuk, I., Morvan, M. L., Antignac, J. P., Gemzell-Danielsson, K., Le Bizec, B., Söder, O., & Svechnikov, K. (2017) · Endocrine Connections · doi:10.1530/ec-17-0085 · Cited by 20 · see citing works
Ishimoto, H., Minegishi, K., Higuchi, T., Furuya, M., Asai, S., Kim, S. H., Tanaka, M., Yoshimura, Y., & Jaffe, R. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2509 · Cited by 18 · see citing works
Wang, H., Huang, M., Peng, R., & Jiang, L. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00358.x · Cited by 18 · see citing works
Ishimoto, H., Muench, M. O., Higuchi, T., Minegishi, K., Tanaka, M., Yoshimura, Y., & Jaffe, R. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1139 · Cited by 15 · see citing works
Savchuk, I., Morvan, M., Søeborg, T., Antignac, J., Gemzell‐Danielsson, K., Bizec, B. L., Söder, O., & Svechnikov, K. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600522 · Cited by 13 · see citing works
Goodyer, C. G., Hall, C. S. G., Branchaud, C., & Giroud, C. J. P. (1977) · Steroids · doi:10.1016/0039-128x(77)90009-5 · Cited by 11 · see citing works
Potential role of increased oxygenation in altering perinatal adrenal steroidogenesis
Agrawal, V., Tee, M. K., Qiao, J., Muench, M. O., & Miller, W. L. (2014) · Pediatric Research · doi:10.1038/pr.2014.194 · Cited by 7 · see citing works
Ishimoto, H., Ginzinger, D. G., Matsumoto, T., Hattori, Y., Furuya, M., Minegishi, K., Tanaka, M., Yoshimura, Y., & Jaffe, R. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2514 · Cited by 7 · see citing works
Mansfield, C. W., Carr, B. R., Faye-Petersen, O. M., Chen, D., Xing, Y., Rainey, W. E., & Parker, C. R. (2011) · Reproductive Sciences · doi:10.1177/1933719111408113 · Cited by 5 · see citing works
Inoue, S., Cho, B. H., Song, C. H., Fujimiya, M., Murakami, G., & Matsubara, A. (2010) · Okajimas Folia Anatomica Japonica · doi:10.2535/ofaj.87.11 · Cited by 3 · see citing works
Embryoid Bodies: An In Vitro Model of Mouse Embryogenesis
Desbaillets, I., Ziegler, U., Groscurth, P., et al. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.02104.x · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
An integrated single-cell analysis of human adrenal cortex development
del Valle, I., Young, M. D., Kildisiute, G., Ogunbiyi, O. K., Buonocore, F., Simcock, I. C., Khabirova, E., Crespo, B., Moreno, N., Brooks, T., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.168177 · Cited by 29 · see citing works
Luconi, M., Sogorb, M. A., Markert, U. R., Benfenati, E., May, T., Wolbank, S., Roncaglioni, A., Schmidt, A., Straccia, M., & Tait, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315828 · Cited by 23 · see citing works
Melau, C., Riis, M. L., Nielsen, J. E., Perlman, S., Lundvall, L., Thuesen, L. L., Hare, K. J., Hammerum, M. S., Mitchell, R. T., Frederiksen, H. W., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02080-8 · Cited by 13 · see citing works
Self-citationThree Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System
Luca, E., Zitzmann, K., Bornstein, S. R., Kugelmeier, P., Beuschlein, F., Nölting, S., & Hantel, C. (2023) · Cancers · doi:10.3390/cancers15184601 · Cited by 10 · see citing works
Single-cell exploration of gonadal somatic cell lineage specification during human sex determination
Lardenois, A., Suglia, A., Moore, C. L., Evrard, B., Noël, L., Rivaud, P., Besson, A., Toupin, M., Blévinal, J., Dumortier, C., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.09.011 · Cited by 6 · see citing works
Schneider, G., Ruggiero, C., Renault, L., Doghman-Bouguerra, M., Durand, N., Hingrai, G., Dijoud, F., Plotton, I., & Lalli, E. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad118 · Cited by 3 · see citing works
Melau, C., Gayete-Mor, B., Riis, M. L., Nielsen, J. E., Dreisler, E., Aaboe, K., Brenøe, P. T., Thuesen, L. L., Hare, K. J., Mitchell, R. T., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1114211 · Cited by 2 · see citing works
Self-citationAdrenocortical organoids: A promising tool for modelling human physiology and translational research
Tedesco, M., Schedl, A., & Neirijnck, Y. (2025) · La Presse Médicale · doi:10.1016/j.lpm.2025.104300 · Cited by 1 · see citing works
An organoid model of the human adrenal cortex identifies drivers of steroidogenesis and zonation
Akkerman, N., Xu, Q., Valdeolivas, A., Okuda, R., Gaspa-Toneu, L., Cubela, I., Richardson, M., Giroud, N., Camp, J. G., & Beumer, J. (2026) · Cell Press Blue · doi:10.1016/j.cpblue.2026.100015 · Cited by 1 · see citing works
Evaluation of Ex Vivo Adrenocorticotropic Hormone Responsiveness of Human Fetal Testis
Schröder, M. A. M., Greenald, D., Lodewijk, R., van Herwaarden, A. E., Span, P. N., Sweep, F. C. G. J., Mitchell, R. T., & der Grinten, H. L. C. (2023) · Endocrinology · doi:10.1210/endocr/bqad165 · Cited by 1 · see citing works
Self-citationPreclinic and Translational Research in Adrenal Malignancies
Rapizzi, E., Abate, A., Tamburello, M., Luconi, M., & Sigala, S. (2024) · Updates in surgery/Updates in surgery series · doi:10.1007/978-3-031-62301-1_20
Melau, C., Riis, M. L., Nielsen, J. E., Perlman, S., Lundvall, L., Thuesen, L. L., Hare, K. J., Hammerum, M. S., Mitchell, R. T., Frederiksen, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16584675
Self-citationMelau, C., Riis, M. L., Nielsen, J. E., Perlman, S., Lundvall, L., Thuesen, L. L., Hare, K. J., Hammerum, M. S., Mitchell, R. T., Frederiksen, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16584672
Self-citationMelau, C., Riis, M. L., Nielsen, J. E., Perlman, S., Lundvall, L., Thuesen, L. L., Hare, K. J., Hammerum, M. S., Mitchell, R. T., Frederiksen, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16584678
Self-citationMola, G., Draskau, M. K., Jørgensen, A., Chalmel, F., Melau, C., Evrard, B., Mandrup, K. R., Hegaard, H. K., Hueg, T. K., Frederiksen, H. W., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01815-z
Self-citation
- Authors
- Melau, C., Nielsen, J. E., Perlman, S., Lundvall, L., Langhoff Thuesen, L., Juul Hare, K., Schou Hammerum, M., Frederiksen, H., Mitchell, R. T., Juul, A., & Jørgensen, A.
- Affiliations
- University of Copenhagen (DK)
- Department of Obstetrics and Gynaecology, Hvidovre University Hospital, Hvidovre, Denmark
- Departmet of Obstetrics and Gynaecology, Herlev University Hospital, Herlev, Denmark
- MRC Centre for Reproductive Health (GB)
- Corresponding author
- Jørgensen, Anne
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2020-11-19
- Volume
- 106
- Issue
- 3
- Pages
- 843-857
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W3102866752
- Semantic Scholar
- fb64fa90fd1502b31e21c523b57b80dd4317f81b
- Cited by
- 16
- References
- 65
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 4
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health
- Lundbeck Foundation (R249-2017-1484)
- Novo Nordic Foundation (NNF19OC0056973)
- Aase and Ejnar Danielsen’s Fund
- Medical Research Council (MR/N022556/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- adrenal steroidogenesis, congenital adrenal hyperplasia, ACTH, ketoconazole, androgen secretion, glucocorticoids, apoptosis, disorders of sex development, mineralocorticoids
- MeSH terms
- Adrenal Glands, Adrenal Hyperplasia, Congenital, Adrenocorticotropic Hormone, Androgens, Cell Survival, Culture Media, Drug Evaluation, Preclinical, Female, Fetus, Glucocorticoids, Humans, Ketoconazole, Models, Biological, Pregnancy, Steroids, Metabolic Networks and Pathways, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review